The worldwide increase in obesity, type-2 diabetes, non-alcoholic liver disease, and cardiovascular diseases has stimulated interest in identifying dietary constituents capable of controlling blood glucose, insulin, and lipids as well as blood pressure, and food intake. The gene discussed is INS; the disease is obesity disorder.